Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma

Tietueen suppeat tiedot
dc.contributor.authorUrpu Salmenniemi
dc.contributor.authorKari Remes
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.converis.publication-id3079702
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/3079702
dc.date.accessioned2022-10-28T14:40:02Z
dc.date.available2022-10-28T14:40:02Z
dc.description.abstractThrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
dc.format.pagerangee13
dc.identifier.eissn2038-8330
dc.identifier.jour-issn2038-8322
dc.identifier.olddbid189574
dc.identifier.oldhandle10024/172668
dc.identifier.urihttps://www.utupub.fi/handle/11111/44671
dc.identifier.urnURN:NBN:fi-fe2021042715030
dc.language.isoen
dc.okm.affiliatedauthorRemes, Kari
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisher.countryItalyen_GB
dc.publisher.countryItaliafi_FI
dc.publisher.country-codeIT
dc.relation.articlenumbere13
dc.relation.ispartofjournalHematology Reports
dc.relation.issue2
dc.relation.volume4
dc.source.identifierhttps://www.utupub.fi/handle/10024/172668
dc.titleThrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
dc.year.issued2012

Tiedostot

Näytetään 1 - 1 / 1
Name:
4001-28444-2-PB.pdf
Size:
632.39 KB
Format:
Adobe Portable Document Format
Lataa

Kokoelmat

Rinnakkaistallenteet